Key Takeaways
- The quarter ended June 30, 2026 delivered a robust earnings beat with net profit at Rs 165.9 crore, up 108.7% year-on-year.
- Revenue from operations climbed 38.5% YoY to Rs 1,785.2 crore and rose 35.8% sequentially.
- EBITDA reached Rs 252.5 crore, up 86.9% YoY and 107.1% QoQ, with margin expanding to 14.1%.
- India led growth with healthy double-digit gains, while AMET remained resilient with a strong sequential recovery.
For investors eyeing the Galaxy Surfactants Share Price, the latest quarterly results provide a telling signal: profitability is reclaiming its stride while margins expand, even as regional dynamics shape the stock's risk-reward profile. The quarter ended June 30, 2026, delivered consolidated net profit of Rs 165.9 crore, up 108.7% from Rs 79.5 crore in the year-ago period. Net profit also surged 165.8% from Rs 62.4 crore in Q4FY26. Revenue from operations rose 38.5% year-on-year to Rs 1,785.2 crore and 35.8% sequentially. EBITDA stood at Rs 252.5 crore, up 86.9% year-on-year and 107.1% sequentially, marking a new milestone for the company.
| Metric | Value |
|---|---|
| Consolidated Net Profit (Q1 FY27) | Rs 165.9 crore |
| YoY Net Profit Growth | 108.7% |
| Net Profit QoQ Growth | 165.8% |
| Revenue From Operations | Rs 1,785.2 crore |
| YoY Revenue Growth | 38.5% |
| QoQ Revenue Growth | 35.8% |
| EBITDA | Rs 252.5 crore |
| EBITDA Margin | 14.1% |
| YoY EBITDA Growth | 86.9% |
| QoQ EBITDA Growth | 107.1% |
| Operating Margin | 14.1% |
| EBITDA Per MT | Rs 35,458 per MT |
| EBITDA Per MT (Last Year) | Rs 20,009 per MT |
| Volume Growth (Overall YoY) | Mid-Single-Digit |
| India Volume Growth | Low Double-Digit |
| ROW Volume Growth | Mid-Single-Digit |
| AMET YoY Volume Change | Declined in Low Single Digits |
These metrics reflect a disciplined product mix and pricing actions that helped the quarter register both higher top-line growth and stronger margins. India’s demand recovery contributed to a favorable volume mix, while the Rest of the World (ROW) segment maintained mid-single-digit volume growth. The Africa, Middle East, and Turkey (AMET) market experienced a year-on-year decline in volumes, but the sequential recovery remained notable, underscoring a broader price and mix-led improvement rather than a pure volume rebound.
Operating efficiency also showed up in the margin expansion. The margin improvement from 10.5% in Q1FY26 to 14.1% in this quarter signals a healthier operating leverage and a better product mix orientation toward higher-margin specialty care products. EBITDA per MT rose meaningfully, reflecting both higher value-added product mix and improved throughput. These dynamics, combined with disciplined pricing actions, point to a sustainable earnings trajectory, even as macro headwinds in raw materials and global logistics continue to pose challenges.
From a strategic perspective, the management highlighted that strategic risk management, supply chain agility, and disciplined commercial decisions helped navigate raw material price volatility and global logistics challenges. The company appears well-positioned to sustain growth in FY27, with a continued emphasis on specialty care products and export markets. Looking ahead, management remains confident in the long-term growth trajectory, anticipating resilient demand in India and a gradual recovery in core global segments. Continued international demand for specialty care products is expected to support growth through FY27.
India’s rebound and the improvement in international demand set the stage for a multi-year growth story, even as geopolitical developments and supply-chain dynamics keep a watchful eye on global trade. The combination of volume resilience, better pricing, and a richer mix of high-margin products contributes to a healthier EBITDA profile and a more durable earnings stream–an encouraging sign for investors watching the Galaxy Surfactants Stock alongside the Galaxy Surfactants Share Price.
Galaxy Surfactants Share Price Momentum After A Strong Quarter
The momentum in the Galaxy Surfactants share price is anchored in a quarter that delivered strong profitability growth and margin expansion. The consolidated net profit of Rs 165.9 crore marks a sharp improvement from the prior-year period, and the 165.8% rise from Q4FY26 confirms a robust sequential uplift. Revenue from operations at Rs 1,785.2 crore demonstrates the company’s ability to sustain demand in a rising price environment, with a YoY gain of 38.5% and a QoQ gain of 35.8%. EBITDA at Rs 252.5 crore, with an 86.9% YoY increase and 107.1% sequential jump, supports a higher operating margin of 14.1% for the quarter, up from 10.5% a year earlier.
From a valuation perspective, the strength in margins and the durability of top-line growth argue for a constructive view on the stock, subject to macro risks and commodity price volatility. EBITDA per MT rose to Rs 35,458, up from Rs 20,009 in the same period last year, signaling improved unit economics and higher profitability per unit of output. The company’s ability to translate volume resilience into earnings resilience bodes well for investors seeking a durable earnings stream and a healthier balance sheet in FY27.
Galaxy Surfactants Earnings: Margin Expansion And EBITDA Per MT
The earnings story centers on operating leverage and a shifting mix toward higher-margin products. The 14.1% EBITDA margin reflects operational efficiency and pricing discipline, a step up from the prior-year margin of 10.5% in Q1 FY26. The growth in EBITDA to Rs 252.5 crore, up 86.9% YoY and 107.1% QoQ, underscores the company’s ability to scale profits even as input costs and logistics pressures persist. The EBITDA per MT at Rs 35,458 confirms that the margin expansion is not merely a function of top-line growth but a result of improved unit economics, supported by better product mix, premium segments, and disciplined pricing actions.
Investors should note that the per-MT profitability improvement–from Rs 20,009 in the prior year–reflects a meaningful uplift in the value realized per tonne produced. This suggests that Galaxy Surfactants is successfully advancing its specialty care and performance surfactants mix, which typically command higher margins and more resilient demand dynamics in varied macro environments.
Galaxy Surfactants Quarterly Results Show Resilience Across Regions
Regionally, the company reported mid-single-digit volume growth overall, with India leading the recovery by returning to low double-digit growth. Meanwhile, ROW maintained mid-single-digit growth, signaling broadening geographic recovery beyond India’s domestic market. In AMET (Africa, Middle East, and Turkey), volumes declined in the low single digits year-on-year but staged a strong sequential recovery, reflecting a sequential improvement in demand and pricing alongside ongoing product mix optimization. This regional mix supports a balanced growth runway, as a diversified geographic footprint helps offset localized cyclicality in any single market.
Management attributed gains to a better product mix, higher contributions from specialty care products, disciplined pricing actions, and demand recovery among Tier-1 FMCG clients. In an environment where raw material costs and global logistics pose volatility, the ability to navigate price changes and supply chains while maintaining volume is a core driver of earnings stability. The quarterly results thus paint a picture of a company executing its growth strategy with improving profitability even as certain markets rebound more slowly than others.
Galaxy Surfactants Stock: Regional Growth And The Road Ahead
Looking ahead, the long-term growth trajectory remains intact on the back of India’s domestic demand and a gradual recovery in core international client segments. Continued international demand for specialty care products is expected to support growth through FY27, complemented by disciplined pricing and enhanced operational efficiency. The company’s resilience under supply chain volatility and geopolitical headwinds bodes well for investors who are looking for quality earnings delivered with improving unit economics and an expanding margin profile. While short-term price volatility can arise from macro and commodity-driven shifts, the underlying growth drivers appear well-placed for a sustained earnings path.
For readers seeking deeper stock-specific analysis, Swastika’s Sarthi AI stock assistant can help tailor insights to your investment thesis. Swastika's Sarthi AI stock assistant offers institutional-grade research on Galaxy Surfactants and peers to help you test scenarios and validate what the quarterly results imply for the Galaxy Surfactants stock and your portfolio.
In a market where every data point can influence a stock’s direction, having access to an AI-driven stock assistant can sharpen your decision framework. Sarthi can help you model different scenarios–how a continued margin expansion could translate into earnings yield, what a potential multiple expansion might imply for Galaxy Surfactants Stock, and how macro variables could impact raw material costs and logistics. The tool is designed to translate complex quarterly data into actionable intelligence for retail investors, complementing your own analysis with data-driven prompts and scenario testing.
Frequently Asked Questions
What was Galaxy Surfactants' consolidated net profit for the quarter ended June 30, 2026?
The company reported a consolidated net profit of Rs 165.9 crore for the quarter ended June 30, 2026, up 108.7% from Rs 79.5 crore in the year-ago period. Net profit also surged 165.8% from Rs 62.4 crore in Q4FY26.
How did Galaxy Surfactants' revenue from operations perform in the quarter ended June 30, 2026?
Revenue from operations rose 38.5% year-on-year to Rs 1,785.2 crore and 35.8% sequentially.
What were the EBITDA and EBITDA margin for Galaxy Surfactants in the quarter?
EBITDA was Rs 252.5 crore, up 86.9% year-on-year and 107.1% sequentially. The operating profit margin broadened to 14.1% during the quarter.
How did EBITDA per MT change year-on-year for Galaxy Surfactants?
EBITDA per metric tonne jumped to Rs 35,458 per MT, compared to Rs 20,009 per MT in the same period last year.
What regional dynamics did Galaxy Surfactants experience in the quarter?
Overall volume growth was mid-single-digit; India led the recovery with low double-digit growth, while ROW delivered mid-single-digit volume expansion. AMET volumes declined only in the low single digits year-on-year but staged a strong sequential recovery.
What is the management's long-term outlook for Galaxy Surfactants?
Management remains confident in a long-term growth trajectory, supported by strategic risk management, supply chain agility, disciplined pricing, and continued international demand for specialty care products through FY27.
Conclusion
The quarter’s numbers reinforce a growth narrative for Galaxy Surfactants that blends stronger top-line growth with healthier margins and improved unit economics. For the Galaxy Surfactants share price, the key takeaway is that profitability is rising on the back of a better product mix and disciplined pricing, supported by a diversified regional footprint. The India recovery and the positive signals from specialty care products suggest that earnings resilience may persist into FY27, even as macro headwinds remain a consideration for global supply chains.
Open your trading and demat account here
Reference :
1 : Economictimes
